Cite
Posoleucel in Kidney Transplant Recipients with BK Viremia: Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial.
MLA
Chandraker, Anil, et al. “Posoleucel in Kidney Transplant Recipients with BK Viremia: Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial.” Journal of the American Society of Nephrology : JASN, vol. 35, no. 5, May 2024, pp. 618–29. EBSCOhost, https://doi.org/10.1681/ASN.0000000000000329.
APA
Chandraker, A., Regmi, A., Gohh, R., Sharma, A., Woodle, E. S., Ansari, M. J., Nair, V., Chen, L.-X., Alhamad, T., Norman, S., Cibrik, D., Singh, M., Alper, A., Jain, D., Zaky, Z., Knechtle, S., Sharfuddin, A., Gupta, G., Lonze, B. E., … Wojciechowski, D. (2024). Posoleucel in Kidney Transplant Recipients with BK Viremia: Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial. Journal of the American Society of Nephrology : JASN, 35(5), 618–629. https://doi.org/10.1681/ASN.0000000000000329
Chicago
Chandraker, Anil, Anil Regmi, Reginald Gohh, Akhil Sharma, E Steve Woodle, Mohammed J Ansari, Vinay Nair, et al. 2024. “Posoleucel in Kidney Transplant Recipients with BK Viremia: Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial.” Journal of the American Society of Nephrology : JASN 35 (5): 618–29. doi:10.1681/ASN.0000000000000329.